FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

134460003: Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3679877015 Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679879017 Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Hydrochlorothiazide and irbesartan only product in oral dose form true Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role Diuretic therapeutic role true Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Product containing irbesartan (medicinal product) false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Diuretic (substance) false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Irbesartan (substance) false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) médicament contenant irbesartan et hydrochlorothiazide false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Hydrochlorothiazide (substance) false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a une forme pharmaceutique (attribut) comprimé false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a une forme pharmaceutique (attribut) Oral tablet true Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Product manufactured as oral dose form (product) false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Angiotensin II receptor antagonist+diuretic (product) false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) Hydrochlorothiazide-containing product in oral dose form false Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Hydrochlorothiazide (substance) false Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Hydrochlorothiazide (substance) false Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 12.5 (qualifier value) false Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) Irbesartan (substance) false Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Irbesartan (substance) false Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 300 (qualifier value) false Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Irbesartan (substance) true Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 300 (qualifier value) false Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Hydrochlorothiazide (substance) true Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value (attribute) 12.5 (qualifier value) false Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Irbesartan (substance) true Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Hydrochlorothiazide (substance) true Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient deux false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start